---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-020308"
form_type: "8-K/A"
ticker: "STEX"
cik: "0001530766"
company_name: "Streamex Corp."
filed_at: "2025-07-21T23:59:59+00:00"
generated_at: "2026-05-18T05:03:05.684567+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BioSig amends 8-K to provide Streamex business overview, risk factors, and pro forma financials

## Summary
- Streamex generated ~$200,000 revenue in Q1 2025; platform still under development with no tokenized assets launched.
- Streamex to tokenize real-world assets starting with gold; competes with Pax Gold ($810M cap) and Securitize ($4B+ tokenized).
- BioSig now operates two segments: healthcare (PURE EP/ViralClear) and tokenized finance through Streamex.
- Streamex holds minority interest in Canadian Exempt Market Dealer license; tokens likely classified as securities.
- Pro forma combined financials filed for periods ended March 31, 2025 and December 31, 2024.

## SEC filing metadata
- accession: 0001641172-25-020308
- form_type: 8-K/A
- ticker: STEX
- cik: 0001530766
- company_name: Streamex Corp.
- filed_at: 2025-07-21T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1530766/000164117225020308/0001641172-25-020308-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1530766/000164117225020308/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-020308
- JSON: https://secwatch.observer/filing/0001641172-25-020308.json
- Plain text: https://secwatch.observer/filing/0001641172-25-020308.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.